Cargando…
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a genetic disease of the myocardium that is relatively common in the general population, with an autosomal dominant inheritance as a genetic basis. Clinical and natural history pathways can be very different among patients with HCM. Treatment strategies have made...
Autores principales: | Autore, Camillo, Francia, Pietro, Tini, Giacomo, Musumeci, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120975/ https://www.ncbi.nlm.nih.gov/pubmed/37091634 http://dx.doi.org/10.1093/eurheartjsupp/suad060 |
Ejemplares similares
-
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023) -
Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act
por: Musumeci, Giuseppe, et al.
Publicado: (2023) -
Predicting left ventricular functional recovery in ischaemic cardiomyopathy: needs and challenges
por: Radesich, Cinzia, et al.
Publicado: (2023) -
Sudden death in ischemic heart disease: looking for new predictors: polygenic risk
por: Boccanelli, Alessandro, et al.
Publicado: (2023) -
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023)